ELVN Prakiraan wutah bathi resik saben saham kanggo taun ngarep enliventherapeutics.com

Logo korporat perusahaan Enliven Corp (ELVN)

Enliven Therapeutics (ELVN) is strengthening its position in precision oncology through patents for selective molecules targeting leukemia. Expectations for changes in net earnings per share demonstrate market adaptability, where -21.10 represents the latest metric reading. Growth potential is based on the development of inhibitors for resistant forms of cancer and the optimization of the cold chain supply through a network of contract laboratories.

ELVN: Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Enliven Therapeutics Inc 28.04.2023 - 18.11.2026

Rincian metrik keuangan lan pasar Enliven Therapeutics, Inc. (ELVN)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Enliven Therapeutics, Inc., ELVN
Produk merek enliventherapeutics.com

Enliven Therapeutics' success in developing selective oncology therapies and its strong patent protection create a foundation for business scaling. The current expected earnings per share growth level -21.10 reflects the analysts' consensus forecast for net income dynamics, allowing investors to assess capitalization potential without a critical increase in debt load.

Perusahaan pesaing

GMAB (Genmab Corp) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep exelixis.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvalent (NUVL)|KYMR (Kymera) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep IDYA (IDEAYA Biosciences Inc)|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep ORIC Pharma|Relay Therapeutics Inc - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Nurix Therapeutics, Inc.|TYRA (Tyra Biosciences, Inc.) - Prakiraan wutah bathi saben saham kanggo taun ngarep|VSTM: Proyeksi tambahing bathi saben saham ing taun ngarep|GLUE (monterosatx.com) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Cullinan Therapeutics Inc CGEM|Prakiraan wutah bathi kanggo taun ngarep IMRX|C4 Therapeutics - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Black Diamond Therapeutics - Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep RPTX|PMVP: Prakiraan wutah bathi saben saham kanggo taun ngarep|karyopharm.com - Proyeksi tambahing bathi saben saham ing taun ngarep|PPCB: Prakiraan wutah bathi kanggo taun ngarep|Bio Green Med Solution Inc - Dinamika bathi saben saham sing diarepake ing taun ngarep|AADI (Aadi Bioscience Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep aileronrx.com ALRN|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Blueprint Medicines Corp. (BPMC)|GLYC (GlycoMimetics) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep SWTX (SpringWorks Therapeutics, Inc)